• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYHS2302607 二甲双胍恩格列净片(Ⅵ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs(4) Generic Drug 2023-09-27 view
CYHS2301032 二甲双胍恩格列净片(Ⅵ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs(4) Generic Drug 2023-04-12 view
CYHS2300816 二甲双胍恩格列净片(Ⅵ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs(4) Generic Drug 2023-03-17 view
CYHS2402431 二甲双胍恩格列净片(Ⅵ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs(4) Generic Drug 2024-07-31 Zhejiang Jianfeng Pharmaceutical Macutical Holdings view
CYHS2300194 二甲双胍恩格列净片(Ⅵ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs(4) Generic Drug 2023-01-19 QILU Pharmaceutical Co Ltd view
CYHS2400553 二甲双胍恩格列净片(Ⅵ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs(4) Generic Drug 2024-02-07 Shandong New Time Pharmaceutical Co Ltd view
JYHB2101090 二甲双胍恩格列净片(Ⅵ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2021-05-11 Boehringer Ingelheim International GmbH view
CYHS2303456 二甲双胍恩格列净片(Ⅵ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs(4) Generic Drug 2023-12-14 Shandong Langnuo Pharmaceutical Co Ltd view
JYHB2002594 二甲双胍恩格列净片(Ⅵ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-12-18 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2021-01-08 view